Part 3/10:
Traditionally, surgeons remove tumors and then suture the site, leaving a significant gap in treatment. This approach misses an opportunity to administer targeted therapies at the precise location and time of surgery. The innovative solution proposed by SURGE Therapeutics involves delivering drugs directly during the surgical process, targeting residual cancer cells immediately after tumor removal. This method offers a promising step toward more effective, localized cancer therapies.